Health Condition 1: null- 1) Biopsy proven carcinoma of cervix 2) Age : more than 18-65 yrs 3) FIGO Stage IIB - IIIB 4) Karnofsky performance scale score 70 or above 5) Normal kidney, liver and bone marrow function
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Biopsy proven carcinoma of cervix 2) Age : more than 18-65 yrs 3) FIGO Stage IIB - IIIB 4) Karnofsky performance scale score 70 or above 5) Normal kidney, liver and bone marrow function 6) Patient who have given informed consent
Exclusion criteria
Exclusion criteria: Early stage cancer FIGO stage IA -IIA 2) Metastatic patients 3) Lack of Histopathological proof of malignancy 4) Doubtful follow-up and /or non-compliance 5) Uncontrolled co-morbid conditions e.g. Hypertension, Diabetes Mellitus, Chronic Obstructive pulmonary disease (COPD), coronary artery disease (CAD), Severe Mental or Physical Disorder 6) Pregnancy 7) Deranged renal, liver function test 8) Patient refusing to give written informed consent 9) H/O- of previous irradiation 10) H/O-of allergy 11)Collagen vascular disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the loco-regional control , short term survival and also dosimetry comparison between conventional and image â?? guided and volume â?? optimized Brachytherapy planning in patients of locally advanced carcinoma cervix treated with WP-IMRT combined with image guided Brachytherapy (IGBT). 2. To assess the acute & late toxicity in patients of locally advanced carcinoma cervix treated with WP-IMRT combined with image guided Brachytherapy (IGBT).Timepoint: TREATMENT COMPLETE WITHIN 8WKS. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the acute & late toxicity in patients of locally advanced carcinoma cervix treated with WP-IMRT combined with image guided Brachytherapy (IGBT).Timepoint: TREATMENT COMPLETE WITHIN 8WKS | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi